Findings

What do systematic reviews say?

6 questions · 6 findings · 5 reviews · Vascular

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 16.7%Low 4 · 66.7%Moderate 1 · 16.7%High 0 · 0%

All‐cause mortality · non‐hospitalised individuals with COVID‐19 (asymptomatic and mild disease)

Anticoagulant showed no clear difference in all‐cause mortality compared with placebo or no treatment (low certainty).

1 finding from 1 review

Prophylactic anticoagulants for non‐hospitalised people with COVID‐19 2023 · Cochrane Headline outcomes only
RR 0.36 [0.04, 3.61]
5 studies · 1777 participants
Low

All‐cause mortality · atherosclerotic cardiovascular disease

EDTA showed no clear difference in all‐cause mortality compared with placebo (low certainty).

1 finding from 1 review

Chelation therapy for atherosclerotic cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.97 [0.73, 1.28]
2 studies · 1792 participants
Low

All‐cause mortalityg · patients with unprovoked venous thromboembolism

Extended prophylaxis showed no clear difference in all‐cause mortalityg compared with placebo (moderate certainty).

1 finding from 1 review

All‐cause mortality, 30 days1 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in all‐cause mortality, 30 days1 compared with placebo (low certainty).

1 finding from 1 review

All‐cause mortality, 6 months1 · patients of any age with AAA less than 30 mm in diameter

Metoprolol showed no clear difference in all‐cause mortality, 6 months1 compared with placebo (low certainty).

1 finding from 1 review

All‐cause mortality up to 30 days · people aged 18 and over undergoing vascular surgery

1 finding from 1 review